CYDX

CYduct Diagnostics, Inc. CYDX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CYDX ESMC TBIO CHYPF EDXC MRZM BINP EPGNF BMMJ LGND
6M -19.44 % -45.60 % 10.00 % 0.00 % -72.50 % 0.00 % -17.50 % 41.77 % -80.00 % 66.76 %
YTD 33.53 % 40.15 % -72.50 % 0.00 % -84.12 % -96.34 % -89.29 % 41.77 % -99.53 % 81.83 %
1Y 33.62 % 30.77 % -71.05 % 0.00 % -88.58 % -98.13 % -89.29 % 41.77 % -99.22 % 73.88 %
3Y -54.06 % 115.19 % -99.49 % -87.19 % -97.56 % -99.95 % -97.36 % 261.29 % -99.87 % 201.21 %
5Y -81.87 % 54.55 % -99.97 % 684 387.11 % -99.00 % -99.99 % -98.43 % -67.35 % -99.97 % 85.89 %
10Y -91.88 % -84.11 % -99.97 % 51 295 943.66 % -94.27 % -99.57 % -99.84 % -57.41 % -99.75 % 81.93 %
From the beginning -100.00 % -99.80 % -99.97 % 51 295 943.66 % -99.99 % -99.97 % -100.00 % -87.34 % -99.83 % 329.95 %

Dividend

Ligand Pharmaceuticals Incorporated